Stocks and InvestingStocks and Investing
Fri, April 19, 2024
Thu, April 18, 2024

Li Watsek Reiterated (ASND) at Buy and Held Target at $173 on, Apr 18th, 2024


Published on 2024-10-28 10:26:56 - WOPRAI, Li Watsek
  Print publication without navigation


Li Watsek of Cantor Fitzgerald, Reiterated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $173 on, Apr 18th, 2024.

Li has made no other calls on ASND in the last 4 months.



There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 0 agree with Li's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Li


  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $167 on, Tuesday, April 2nd, 2024
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $260 on, Friday, March 15th, 2024
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $225 on, Thursday, February 8th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $182 on, Thursday, February 8th, 2024
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $150 on, Wednesday, December 20th, 2023